BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25105253)

  • 1. Effects of Streptococcus thermophilus on volatile sulfur compounds produced by Porphyromonas gingivalis.
    Lee SH; Baek DH
    Arch Oral Biol; 2014 Nov; 59(11):1205-10. PubMed ID: 25105253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro.
    Yoo HJ; Jwa SK; Kim DH; Ji YJ
    Clin Exp Dent Res; 2020 Apr; 6(2):207-214. PubMed ID: 32250565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of malodorous gas formation by oral bacteria with cetylpyridinium and zinc chloride.
    Kang JH; Kim DJ; Choi BK; Park JW
    Arch Oral Biol; 2017 Dec; 84():133-138. PubMed ID: 28987726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of spirochetes and porphyromonus gingivalis on oral malodor].
    Zhu WD; Sha YQ; Chen ZB
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 May; 38(3):206-9. PubMed ID: 12887800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of
    Huang P; Yuan S; Xu X; Peng X
    J Breath Res; 2022 Nov; 17(1):. PubMed ID: 36301704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of Melaleuca alternifolia essential oil on growth and production of volatile sulphur compounds by oral bacteria.
    Graziano TS; Calil CM; Sartoratto A; Franco GC; Groppo FC; Cogo-Müller K
    J Appl Oral Sci; 2016; 24(6):582-589. PubMed ID: 28076463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of cetylpyridinium chloride buccal tablets on halitosis induced by oral conditions].
    Zhang D; Liu CH; Zhang J; Cai D; Yang X; Li S; Zhong H
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Aug; 34(9):1386-9. PubMed ID: 25263382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetylpyridinium chloride suppresses gene expression associated with halitosis.
    Liu J; Ling JQ; Wu CD
    Arch Oral Biol; 2013 Nov; 58(11):1686-91. PubMed ID: 24112735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tea catechin EGCg suppresses the mgl gene associated with halitosis.
    Xu X; Zhou XD; Wu CD
    J Dent Res; 2010 Nov; 89(11):1304-8. PubMed ID: 20858778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of volatile sulfur compound production by Solobacterium moorei.
    Tanabe S; Grenier D
    Arch Oral Biol; 2012 Dec; 57(12):1639-43. PubMed ID: 23088790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of methionine gamma lyase deaminase and the growth of Porphyromonas gingivalis: A therapeutic target for halitosis/periodontitis.
    Kandalam U; Ledra N; Laubach H; Venkatachalam KV
    Arch Oral Biol; 2018 Jun; 90():27-32. PubMed ID: 29525436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative detection of volatile sulfur compound- producing microorganisms in oral specimens using real-time PCR.
    Kato H; Yoshida A; Awano S; Ansai T; Takehara T
    Oral Dis; 2005; 11 Suppl 1():67-71. PubMed ID: 15752104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Probiotics, Streptococcus salivarius K12 and M18, Suppress the Release of Volatile Sulfur Compounds and a Virulent Protease from Oral Bacteria: An In-Vitro Study.
    Park JA; Lee GR; Lee JY; Jin BH
    Oral Health Prev Dent; 2023 Aug; 21():259-270. PubMed ID: 37724895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.
    Burton JP; Chilcott CN; Moore CJ; Speiser G; Tagg JR
    J Appl Microbiol; 2006 Apr; 100(4):754-64. PubMed ID: 16553730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a mouthwash containing ε-poly-L-lysine, funme peptides and domiphen in reducing halitosis and supragingival plaque: a randomized clinical trial.
    Shen S; Liu X; Huang J; Sun Y; Liu B; Song W; Meng L; Du M; Feng Q
    BMC Oral Health; 2024 May; 24(1):525. PubMed ID: 38702623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory Effect of
    Suzuki N; Higuchi T; Nakajima M; Fujimoto A; Morita H; Yoneda M; Hanioka T; Hirofuji T
    Int J Dent; 2016; 2016():8241681. PubMed ID: 27799940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between oral malodour and periodontal disease-related parameters in the general population.
    Apatzidou AD; Bakirtzoglou E; Vouros I; Karagiannis V; Papa A; Konstantinidis A
    Acta Odontol Scand; 2013 Jan; 71(1):189-95. PubMed ID: 22339235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiological results of improvement in periodontal condition by administration of oral probiotics.
    Inchingolo F; Dipalma G; Cirulli N; Cantore S; Saini RS; Altini V; Santacroce L; Ballini A; Saini R
    J Biol Regul Homeost Agents; 2018; 32(5):1323-1328. PubMed ID: 30334433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halitosis vaccines targeting FomA, a biofilm-bridging protein of fusobacteria nucleatum.
    Liu PF; Huang IF; Shu CW; Huang CM
    Curr Mol Med; 2013 Sep; 13(8):1358-67. PubMed ID: 23865430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between halitosis and periodontal disease - associated oral bacteria in tongue coatings.
    Amou T; Hinode D; Yoshioka M; Grenier D
    Int J Dent Hyg; 2014 May; 12(2):145-51. PubMed ID: 23890391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.